Vitrolife Expands Its IVF Product Portfolio Through Acquisition in the USA

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Vitrolife (STO:VITR) is acquiring the business in Conception Technologies, USA. This means that Vitrolife will broaden their IVF product portfolio, increase cost-efficient production capacity and increase its market share, above all in North America.
MORE ON THIS TOPIC